Literature DB >> 11805026

Immunoassay for serum glutamine synthetase in serum: development, reference values, and preliminary study in dementias.

Miyoko Takahashi1, Eric Stanton, J Ignacio Moreno, George Jackowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11805026

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients.

Authors:  Gulnur Sh Burbaeva; Irina S Boksha; Elena B Tereshkina; Olga K Savushkina; Lubov' I Starodubtseva; Marina S Turishcheva
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

Review 2.  Biomarkers in translational research of Alzheimer's disease.

Authors:  Rawan Tarawneh; David M Holtzman
Journal:  Neuropharmacology       Date:  2010-04-13       Impact factor: 5.250

3.  Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease.

Authors:  Yannick Vermeiren; Nathalie Le Bastard; Christopher M Clark; Sebastiaan Engelborghs; Peter P De Deyn
Journal:  Neurochem Res       Date:  2011-05-20       Impact factor: 3.996

4.  Brain type carnosinase in dementia: a pilot study.

Authors:  Cynthia M Balion; Carolyn Benson; Parminder S Raina; Alexandra Papaioannou; Christopher Patterson; Afisi S Ismaila
Journal:  BMC Neurol       Date:  2007-11-05       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.